BMI与肺动脉压力存在因果关联但不导致肺血管重塑
本研究采用两样本逆方差加权孟德尔随机化设计,利用两个BMI遗传风险评分在右心导管和超声心动图队列中分析BMI与肺动脉压力及肺血管重塑的关系。结果显示直接测量的BMI和多基因风险评分均与肺动脉压力正相关,但不与肺血管重塑标志物相关;孟德尔随机化支持较高BMI因果性导致较高收缩期肺动脉压,且该关系在排除PAH或PVH个体后仍存在。BMI是PAH和PVH中肺动脉高压严重程度的修饰因素,但仅参与PVH的发病机制。
要点
- BMI与肺动脉压力正相关,但与肺血管重塑标志物无关
- 孟德尔随机化支持较高BMI因果性导致较高收缩期肺动脉压
- BMI仅参与PVH发病机制,不参与PAH发病机制
核心结论
- BMI是PAH和PVH中肺动脉高压严重程度的修饰因素,但仅参与PVH的发病机制。
- 孟德尔随机化支持较高BMI因果性导致较高收缩期肺动脉压。
研究设计与样本
- 研究设计为两样本逆方差加权孟德尔随机化。
- 从全基因组关联研究汇总数据构建两个BMI遗传风险评分,并应用于非重叠的右心导管或超声心动图受试者队列。
主要发现
- 在所有受试者中,直接测量的BMI和高多基因风险评分均与肺动脉压力正相关,但与肺血管重塑标志物无关。
- 分类分析显示BMI和高多基因风险评分与PVH相关,但与PAH无关。
- 严格遗传风险评分的孟德尔随机化支持较高BMI因果性导致较高收缩期肺动脉压。
- 敏感性分析显示排除PAH或PVH个体后,收缩期肺动脉压与BMI严格遗传风险评分的关系仍保留。
- 在超声心动图队列中,BMI和高多基因风险评分与估测肺动脉压力及左心重塑标志物正相关。
临床怎么用
- 临床评估肺动脉高压患者时应考虑BMI对肺动脉压力的影响,但需区分PAH与PVH的发病机制差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is an unclear relationship of obesity to the pathogenesis and severity of pulmonary arterial hypertension (PAH) and pulmonary venous hypertension (PVH). RESEARCH QUESTION: Is BMI casually associated with pulmonary artery pressure (PAP) and/or markers of pulmonary vascular remodeling? STUDY DESIGN AND METHODS: The study design was a two-sample inverse-variance weighted Mendelian randomization. We constructed two BMI genetic risk scores from genome-wide association study summary data and deployed them in nonoverlapping cohorts of subjects referred for right heart catheterization (RHC) or echocardiography. A BMI highly polygenic risk score (hpGRS) optimally powered to detect shared genetic architecture of obesity with other traits was tested for association with RHC parameters including markers of pulmonary vascular remodeling. A BMI strict genetic risk score (sGRS) composed of high-confidence genetic variants was used for Mendelian randomization analyses to assess if higher BMI causes higher PAP. RESULTS: Among all subjects, both directly measured BMI and hpGRS were positively associated with pulmonary arterial pressures but not markers of pulmonary vascular remodeling. Categorical analyses revealed BMI and hpGRS were associated with PVH but not PAH. Mendelian randomization of the sGRS supported that higher BMI is causal of higher systolic pulmonary artery pressure (sPAP). Sensitivity analyses showed sPAP-BMI sGRS relationship was preserved when either individuals with PAH or PVH were excluded. In the echocardiographic cohort, BMI and hpGRS were positively associated with estimated PAP and markers of left heart remodeling. INTERPRETATION: BMI is a modifier of pulmonary hypertension severity in both PAH and PVH but is only involved in the pathogenesis of PVH.
引用
- Thayer TE, Levinson RT, Huang S, et al. BMI Is Causally Associated With Pulmonary Artery Pressure But Not Hemodynamic Evidence of Pulmonary Vascular Remodeling. Chest. 2020. PMID: 32712226. doi:10.1016/j.chest.2020.07.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。